Pooled human albumin primes neutrophils

Area of Science:

• Biochemistry
• Immunology
• Surgical Research

Background:

• Human pooled albumin is traditionally used in cardiopulmonary bypass circuits and for post-surgical volume expansion.
• Albumin's routine use in cardiac surgery necessitates evaluating its physiological and financial implications.
• Albumin non-selectively binds plasma proteins and lipids, potentially confounding its effects.

Purpose of the Study:

• To investigate the direct influence of purified albumin, free of bound lipids and globulins, on human neutrophil activation.
• To compare the effects of purified albumin with clinically available pooled albumin on human neutrophils.
• To differentiate the effects of albumin itself from those of its bound components on neutrophil function.

Main Methods:

• Experiments utilized receptor-dependent (FMLP) and receptor-independent (PMA) activation pathways for human neutrophils.
• Assessed neutrophil priming and activation by measuring elastase release.
• Compared the effects of highly purified albumin with standard human pooled albumin.

Main Results:

• Both pooled and purified human albumin demonstrated a dose-dependent priming and activation effect on human neutrophils.
• Elastase release, an indicator of neutrophil activation, was observed with both albumin preparations.
• The findings suggest albumin itself, independent of bound substances, can influence neutrophil activity.

Conclusions:

• The routine administration of albumin in cardiac surgery patients is increasingly difficult to justify.
• Albumin's direct effect on neutrophil activation raises concerns about its routine use.
• Further research is needed to fully elucidate the clinical implications of albumin-induced neutrophil activation in surgical contexts.